Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men
NCT ID: NCT06472817
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
80 participants
OBSERVATIONAL
2023-09-05
2026-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Risk Factors and Discrimination in Cancer Survivorship
NCT05301114
Improving Health Literacy in African-American Prostate Cancer Patients
NCT03322891
Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida
NCT07215039
A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2
NCT02973022
Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans
NCT00476580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To employ the social determinant of migrant health framework (International Organization for Migration, n.d.) to examine the impact of immigration on the health-seeking behaviors of SSAI including informed-decision making, psychosocial effects and coping mechanisms. (Phase I) II. To examine SDOMH factors among SSAI and CI men, including their migration experience and health behaviors. (Phase II)
OUTLINE: This is an observational study.
AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study.
AIM II: Participants complete an interview in person, over the phone, or via zoom on study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational
AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study.
AIM II: Participants complete an interview in person, over the phone, or via zoom on study.
Non-Interventional Study
Non-interventional study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Interventional Study
Non-interventional study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult men originally from each of these geographic regions (East, West, Central, and Southern Africa) and have been diagnosed with prostate cancer
* Able to provide written consent and conduct an interview
* Able to speak and understand English
* PHASE II:
* Caribbean Immigrant men and SSAI men diagnosed with CaP within the last 10 years who identify as Black and speak English
* Able to provide written consent and conduct an interview
* Able to speak and understand English
Exclusion Criteria
* Patients below the ages of 18, and those not belonging to any of four regions
* Employees of Mayo Clinic will be excluded
* Non-English speakers will not be included
* PHASE II:
* Individuals below the age of 18
* Those not diagnosed with prostate cancer and individuals not from the regions described above
* Employees of Mayo Clinic will be excluded
* Non-English speakers will not be included
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Congressionally Directed Medical Research Programs
FED
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gladys B. Asiedu, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Georgia State University
Atlanta, Georgia, United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-03996
Identifier Type: REGISTRY
Identifier Source: secondary_id
17109
Identifier Type: OTHER
Identifier Source: secondary_id
22-005329
Identifier Type: OTHER
Identifier Source: secondary_id
W81XWH-22-1-0971
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
22-005329
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.